CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 547 enrolled
Drug / intervention
Serum proteomicsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01604798
NCT01604798N/ACompleted
CompareCT.gov

Serum Proteomic Profiling for the Early Diagnosis of Colorectal Cancer

Fudan University·observational·Posted May 24, 2012·Updated May 24, 2012

In Brief

An observational study evaluating Serum proteomics for Colorectal Neoplasms. Completed, enrolled 547 participants across 1 site.

Detailed Summary

No ideal serum biomarker currently exists for the early diagnosis of colorectal cancer (CRC). Therefore, it is urgent that accurate and reliable serum biomarkers be identified.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Neoplasms
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 24, 2012
Enrollment StartJan 1, 2007
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 14.1 years ago

Interventions

Serum proteomicsother

magnetic bead-based fractionation coupled with matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry